C4 Therapeutics Engages in Dynamic Healthcare Conference
C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company focused on advancing targeted protein degradation science, is excited to share their participation at a significant healthcare conference. The 8th Annual Evercore Healthcare Conference in Coral Gables will provide a platform for discussing their innovative approach to medicine.
Event Participation Overview
Management from C4 Therapeutics will be featured in a fireside chat within the event, allowing them to connect with industry professionals and investors. This chat is scheduled for a prime time slot on Wednesday, December 3rd, providing an excellent opportunity to delve into the company's breakthrough advancements.
Fireside Chat Details
During this session, key insights into the company’s trajectory will be discussed. Attendees can tune in on December 3rd at 3:25 PM ET, making it a can’t-miss moment for those interested in understanding the future of protein degradation therapies.
About C4 Therapeutics
C4 Therapeutics stands at the forefront of biopharmaceutical advancements. With a focused commitment to targeted protein degradation, the company aims to revolutionize the treatment of various diseases. Utilizing innovative platforms such as TORPEDO, they design and enhance small-molecule medicines specifically targeting difficult-to-treat conditions.
Transforming Healthcare Through Innovation
The mission at C4 Therapeutics is clear: to leverage body mechanisms for degrading disease-causing proteins. This unique strategy not only holds the potential to diminish drug resistance but also aims to create new avenues for patient treatment and recovery, improving outcomes significantly.
Continued Progress in Clinical Studies
Currently, C4T is advancing several targeted oncology programs through clinical studies, marking significant steps toward groundbreaking therapies. Their commitment to clinical excellence positions them as a leader in the biopharmaceutical landscape.
Investor Engagement
For those interested in staying updated on C4 Therapeutics’ journey and novel developments, management encourages participation in their presentations and discussions. The archived replay of the webcast will be accessible after the live event, ensuring that all stakeholders can engage with the content.
Contact Information
To reach out for investor inquiries, connect with Courtney Solberg, Associate Director of Investor Relations at CSolberg@c4therapeutics.com. For media inquiries, Loraine Spreen, Senior Director of Corporate Communications & Patient Advocacy can be contacted at LSpreen@c4therapeutics.com. The team is dedicated to fostering communication and exploring new opportunities in the realm of targeted therapy.
Frequently Asked Questions
What is the focus of C4 Therapeutics?
C4 Therapeutics is primarily focused on targeted protein degradation, aiming to develop innovative therapeutics that enhance patient outcomes.
Where will the conference take place?
The 8th Annual Evercore Healthcare Conference will be held in Coral Gables, providing an opportunity for attendees to engage with industry leaders.
When will the fireside chat occur?
The fireside chat featuring C4 Therapeutics will take place on December 3rd at 3:25 PM ET.
How can investors stay informed about developments at C4 Therapeutics?
Investors can access the live webcast and archived replays on the company’s website, ensuring they remain updated on the latest advancements.
Who can be contacted for investor inquiries?
Investors can reach out to Courtney Solberg at C4 Therapeutics for inquiries related to the company and its innovations.
